Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
The Lancet. Oncology|December 29, 2009
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort studyDavid Olmos, Sophie Postel-Vinay, L Rhoda Molife, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid CancersJena D French, Bryan R Haugen, Francis P Worden, et al.
Head & Neck|January 17, 2012
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR statusMatthew E Spector, K Kelly Gallagher, Emily Light, et al.
Investigational New Drugs|October 11, 2015
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancerPaul L Swiecicki, Lili Zhao, Emily Belile, et al.
The Oncologist|May 14, 2021
Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB TrialAlon Kahana, Shelby P Unsworth, Christopher A Andrews, et al.
Oral Oncology|August 18, 2016
Predictors of severe long-term toxicity after re-irradiation for head and neck cancerJae Y Lee, Krithika Suresh, Rebecca Nguyen, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Oncotarget|July 1, 2021
Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinomaCatherine T Haring, Chandan Bhambhani, Collin Brummel, et al.
Head & Neck|March 5, 2015
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic reviewPrimož Strojan, Jan B Vermorken, Jonathan J Beitler, et al.
Head & Neck|August 22, 2012
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerShamir P Chandarana, Julia S Lee, Eric J P Chanowski, et al.
Pageof 14